Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 7/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | CTSL | P07711 | 7/20 | 0.37 |
| ▸ | CTSB | P07858 | 7/20 | 0.37 |
| ▸ | CTSS | P25774 | 7/20 | 0.37 |
| ▸ | CTSK | P43235 | 7/20 | 0.37 |
| ▸ | F2 | P00734 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13448168 | 0.87 | ACE (0.42) | ACEMEN1KMT2AUSP2LMNA | |
| SCHEMBL13448396 | 0.83 | ACE (0.44) | ACEMEN1KMT2AUSP2LMNA | |
| SCHEMBL13448379 | 0.82 | ACE (0.44) | ACEMEN1KMT2AUSP2LMNA | |
| SCHEMBL13448173 | 0.77 | ACE (0.45) | ACEMEN1KMT2AUSP2LMNA | |
| SCHEMBL13448164 | 0.77 | ACE (0.43) | ACEMEN1KMT2AUSP2LMNA | |
| SCHEMBL8279523 | 0.77 | CTSL (0.62) | CTSLCTSBCTSSCTSK | |
| SCHEMBL13413341 | 0.77 | CTSL (0.62) | CTSLCTSBCTSSCTSK | |
| SCHEMBL13016703 | 0.77 | CTSL (0.62) | CTSLCTSBCTSSCTSK | |
| SCHEMBL13448167 | 0.76 | ACE (0.40) | ACEMEN1KMT2AUSP2LMNA | |
| SCHEMBL13448383 | 0.75 | ACE (0.41) | ACEMEN1KMT2AUSP2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7683033-B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-03-23 | — | — | US | disclosed |